QCOM
82
2
SBUX
27
2
LNC
49
9
VRSK
66
7
PEG
57
2
CPB
44
-5
FFIV
58
2
FITB
60
2
NSC
42
2
MKC
44
2
BLK
61
3
PLD
55
4
ROP
65
2
NUE
44
5
SIG
70
-2
TXN
39
3
WMB
67
3
CMS
64
2
WFC
60
2
LEN
60
4
QCOM
82
2
SBUX
27
2
LNC
49
9
VRSK
66
7
PEG
57
2
CPB
44
-5
FFIV
58
2
FITB
60
2
NSC
42
2
MKC
44
2
BLK
61
3
PLD
55
4
ROP
65
2
NUE
44
5
SIG
70
-2
TXN
39
3
WMB
67
3
CMS
64
2
WFC
60
2
LEN
60
4
Financhill
Back

ProPhase Labs Stock Price Chart

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly
Buy
54

PRPH
ProPhase Labs

Last Price:
5.47
Seasonality Move:
10.94%

7 Day Trial

ALL ACCESS PASS

$ 7

MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold

The result is a select group of high-quality blue-chip stocks.
  • The current trend is relatively stagnant and PRPH is experiencing slight buying pressure.

ProPhase Labs Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 4.97 Buy
20-day SMA: 5.61 Sell
50-day SMA: 5.51 Sell
200-day SMA: 5.13 Buy
8-day EMA: 5.16 Buy
20-day EMA: 5.41 Buy
50-day EMA: 5.48 Sell
200-day EMA: 5.64 Sell

ProPhase Labs Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 49.1 Sell
Chaikin Money Flow: 17916 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.01 - 6.65) Sell
Bollinger Bands (100): (4.55 - 5.85) Buy

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for ProPhase Labs Stock

Is ProPhase Labs Stock a Buy?

  • ProPhase Labs share price is 5.42 while PRPH 8-day simple moving average is 4.97, which is a Buy signal.
  • The stock price of PRPH is 5.42 while ProPhase Labs 20-day SMA is 5.61, which makes it a Sell.
  • ProPhase Labs 50-day simple moving average is 5.51 while PRPH share price is 5.42, making it a Sell technically.
  • PRPH stock price is 5.42 and ProPhase Labs 200-day simple moving average is 5.13, creating a Buy signal.

PRPH Technical Analysis vs Fundamental Analysis

Buy
54
ProPhase Labs (PRPH) is a Buy

Is ProPhase Labs a Buy or a Sell?

  • ProPhase Labs stock is rated a Buy
    The current ProPhase Labs [PRPH] share price is $5.42. The Score for PRPH is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.

ProPhase Labs Stock Info

Market Cap:
103.41M
Price in USD:
5.42
Share Volume:
38.39K

ProPhase Labs 52-Week Range

52-Week High:
9.94
52-Week Low:
4.05
Buy
54
ProPhase Labs (PRPH) is a Buy

ProPhase Labs Share Price Forecast

  • What is the ProPhase Labs stock price today?
    The ProPhase Labs stock price is 5.42 USD today.
  • Will PRPH stock go up or go down?
    ProPhase Labs> share price is forecast to RISE/FALL based on technical indicators
  • Is ProPhase Labs overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProPhase Labs is not overvalued.

Is ProPhase Labs Stock a Buy?

  • ProPhase Labs share price is 5.42 while PRPH 8-day exponential moving average is 5.16, which is a Buy signal.
  • The stock price of PRPH is 5.42 while ProPhase Labs 20-day EMA is 5.41, which makes it a Buy.
  • ProPhase Labs 50-day exponential moving average is 5.48 while PRPH share price is 5.42, making it a Sell technically.
  • PRPH stock price is 5.42 and ProPhase Labs 200-day simple moving average is 5.64, creating a Sell signal.

Fundamental Analysis of ProPhase Labs

Is ProPhase Labs a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.09 per share, and an increase next year of $1.31 per share.

Technical Analysis of ProPhase Labs

Should I short ProPhase Labs stock?

* ProPhase Labs stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.